Evogene and DuPont Pioneer expand soybean collaboration

– The research collaboration is for the development of soybean varieties displaying resistance to Asian Soybean Rust (ASR).   – (NYSE: DD) and Ltd. (TASE: EVGN)  today announced a research More...

Compugen drug discovery company signs $500 million agreement with Bayer

– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan Shavit More...